Delisting riskPopularity #4,543
MDXH · NASDAQ · Medical - Diagnostics & Research

MDxHealth (MDXH)

Molecular prostate-cancer tests for testing and treatment decisions.

$0.6031
vs last close+0.00 (+0.53%)